January 2017 brought together major influences in personalized medicine from all over the world to discuss ongoing advances in PGx, as well as looking forward into the future of precision patient care. Pharmacogenomics continues to rocket forward in clinical utility; the FDA now has 233 medications containing pharmacogenomic information for patients. The Silicon Valley-based PWMC concentrated on the need for patients to advocate for their individual health histories to be at the forefront of their care, which will require continued education, "ensuring that new tools and technology in health and wellness reach as many people as possible."

“Our success will be depend upon engaging both patients and healthy people who become convinced that their contributions will benefit the health and wellbeing of themselves, their children and their grandchildren,” (Sam Hawgood, UCSF Chancellor)

Interested in how personalized medicine can be used in your life and health care? Read more in the original article below from UCSF, and get started here.